RxDoctor Payments Data

Amelia Lammers

Adult Health · Melbourne, FLNPI 1558807669

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations.

$1,341in general payments, 2019–2025

Across 71 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$205
  • Novartis$146
  • Lilly USA, LLC$115
  • Amarin Pharma, Inc.$111
  • Amgen$101
  • Novo Nordisk$95
  • plus $568 from 20 others

What the payments were for

  • Food & beverage$1,32699%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,341 in reported general payments places this provider in the 65th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida →

Other adult health in Melbourne

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →